Evidence map›Paper›PMID 26968097›Full record

ArticleBiochimica et biophysica acta2016

Dietary DHA supplementation causes selective changes in phospholipids from different brain regions in both wild type mice and the Tg2576 mouse model of Alzheimer's disease.

Cécile Bascoul-Colombo, Irina A Guschina, Benjamin H Maskrey, Mark Good, Valerie B O'Donnell, John L Harwood

Open access · hybridAbstract read
In one paragraph

Article in Biochimica et biophysica acta, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 71 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Dynamics of the human skin mediator lipidome in response to dietary ω-3 fatty acid supplementation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Cécile Bascoul-ColomboSchool of Biosciences, Cardiff University, Cardiff CF10 3AX, UK; School of Psychology, Cardiff University, Cardiff CF10 3AT, UK.
Irina A GuschinaSchool of Biosciences, Cardiff University, Cardiff CF10 3AX, UK.
Benjamin H MaskreySchool of Medicine, Cardiff University, Cardiff CF14 4XN, UK.
Mark GoodSchool of Psychology, Cardiff University, Cardiff CF10 3AT, UK.
Valerie B O'DonnellSchool of Medicine, Cardiff University, Cardiff CF14 4XN, UK.
John L HarwoodSchool of Biosciences, Cardiff University, Cardiff CF10 3AX, UK. Electronic address: Harwood@cardiff.ac.uk.
Cardiff University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is of major concern in ageing populations and we have used the Tg2576 mouse model to understand connections between brain lipids and amyloid pathology. Because dietary docosahexaenoic acid (DHA) has been identified as beneficial, we compared mice fed with a DHA-supplemented diet to those on a nutritionally-sufficient diet. Major phospholipids from cortex, hippocampus and cerebellum were separated and analysed. Each phosphoglyceride had a characteristic fatty acid composition which was similar in cortex and hippocampus but different in the cerebellum. The biggest changes on DHA-supplementation were within ethanolamine phospholipids which, together with phosphatidylserine, had the highest proportions of DHA. Reciprocal alterations in DHA and arachidonate were found. The main diet-induced alterations were found in ethanolamine phospholipids, (and included their ether derivatives), as were the changes observed due to genotype. Tg mice appeared more sensitive to diet with generally lower DHA percentages when on the standard diet and higher relative proportions of DHA when the diet was supplemented. All four major phosphoglycerides analysed showed age-dependent decreases in polyunsaturated fatty acid contents. These data provide, for the first time, a detailed evaluation of phospholipids in different brain areas previously shown to be relevant to behaviour in the Tg2576 mouse model for AD. The lipid changes observed with genotype are consistent with the subtle alterations found in AD patients, especially for the ethanolamine phospholipid molecular species. They also emphasise the contrasting changes in fatty acid content induced by DHA supplementation within individual phospholipid classes.

Indexed as

Dietary SupplementsAlzheimer DiseaseAnimalsBrainCerebellumCerebral CortexChromatography, High Pressure LiquidChromatography, Reverse-PhaseDisease Models, AnimalDocosahexaenoic AcidsFatty AcidsGlycerophospholipidsHippocampusHumansLipid MetabolismMice, TransgenicDocosahexaenoic AcidsFatty AcidsGlycerophospholipidsphosphatidylethanolaminePhosphatidylethanolaminesPhosphatidylserinesPhospholipids2576 mouse modelAlzheimer's diseaseBrain areasDHA-enriched dietPhospholipid lipidomics

Identifiers

PMID26968097
PMCPMC4847476
OpenAlexW2296216878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.